Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $89.2100 (-2.09%) ($89.2100 - $89.2100) on Wed. Sep. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.73% (three month average) | RSI | 28 | Latest Price | $89.2100(-2.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.9% a day on average for past five trading days. | Weekly Trend | LGND declines -2.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(50%) IWN(49%) IWO(49%) IWC(47%) IBB(45%) | Factors Impacting LGND price | LGND will decline at least -1.365% in a week (0% probabilities). UUP(-17%) VXX(-16%) TBT(-9%) VIXM(-6%) UNG(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.365% (StdDev 2.73%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $96.83 | 5 Day Moving Average | $93.42(-4.51%) | 10 Day Moving Average | $93.03(-4.11%) | 20 Day Moving Average | $96.83(-7.87%) | To recent high | -17.2% | To recent low | 19.9% | Market Cap | $1.434b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |